The "effects" of Rev-1 vaccination of sheep and goats on human brucellosis in Greece

Vaccination of young animals (3-6-month-old sheep and goats) with Rev-1 vaccine for 15 years in Greece, importantly decreased the abortions in sheep and goats as well as the incidence of brucellosis in humans. After the stop of vaccination in 1994, all over Greece, the prevalence of brucellosis in animals and the incidence in humans quickly increased. It was a positive rank correlation (0.90) among these variables. Once an emergency mass-vaccination programme of young and adult animals with Rev-1 vaccine was started in 1998, the human incidence again decreased. The association of the vaccination coverage of animals and incidence of brucellosis in humans was not linear; the decrease in human brucellosis incidence was observed when the vaccination coverage of animals was >30%. (C) 2004 Elsevier B.V. All rights reserved

The contribution of laboratory animals to diagnostic imaging research in Greece

Biomedical research in Greece has rapidly developed during the last 30 years. Diagnostic imaging groundwork is a significant field of interest which has been developed by taking advantage of the basic and applied research capacities including the use of small and large animal models, conventional and/or genetically modified ones. This important outbreak in research has been enhanced by the construction of modern facilities in universities, medical and other academic research centers, the use of new advanced installed equipment, modern imaging techniques, specific contrast media and, of course, specialized personnel. In this manuscript, the research performed regarding diagnostic imaging techniques using animal models in Greece since 1983 is presented. More specifically a recording of the Greek research centers, the number of researchers, species and figures of animal models, diagnostic imaging techniques used, as well as the contribution of projects in the evolution of diagnostic imaging in medicine and veterinary science is presented. © 2018 S Tselepidis, K Vassiou, D Arvanitis, C Kalogeropoulou, K Marinou

Validation of fluorescence polarization assay (FPA) and comparison with other tests used for diagnosis of B. melitensis infection in sheep

Fluorescence polarization assay (FPA) is a new test for the serological diagnosis of Brucella spp. infection in animals. The FPA is validated for the diagnosis of B. melitensis infection in sheep. For this purpose, 166 sera originated from natural infected sheep (verified by culture) and 851 sera originated from healthy animals (reared in areas where B. melitensis was never been isolated) were tested. The optimum cut-off value that offers the highest diagnostic sensitivity (DSn) and diagnostic specificity (DSp) was determined at 87 mP with the use of ROC analysis. The DSn and DSp of FPA using this cut-off value are calculated at 97.6 and 98.9% with a 95% confidence interval (CI) of 93.9-99.3% and 98.0-99.5%, respectively. The DSn and DSp of FPA have been assessed also using as positive reference (n = 587), sera that gave positive results at least in two tests used for diagnosis of B. melitensis in sheep as Rose Bengal Test (RBT), modified Rose Bengal Test (m-RBT), complement fixation test (CFT), indirect Elisa (i-Elisa) and competition Elisa (c-Elisa) originated from animals reared in flocks infected by B. melitensis. The optimum cut-off value using the above panel of positive reference sera was the same offering a DSn of 95.9% with a 95% Cl, 94.0-97.4%, since the DSp remains the same. The DSn and DSp as well as performance, accuracy and agreement of FPA's result were compared with those of other tests used. The accuracy of FPA is very high, similar with that of i-Elisa. FPA is a promising assay, which offers a DSn and accuracy better that of those of the tests currently approved for the diagnosis of B. melitensis in sheep and goats. Due to its simplicity, the sort time that results can be obtained and its accuracy it can be used and improve the laboratory testing capacity as well as the efficacy of the eradication program based on test-and-slaughter policy. (c) 2005 Elsevier B.V. All rights reserved